S. Coulibaly

发表

Integrative genomic analysis reveals mechanisms of immune evasion in P. falciparum malaria

Nizar Drou, Y. Idaghdour, S. Sirima, 2020, Nature Communications.

Lessons learned from the use of HRP-2 based rapid diagnostic test in community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso

S. Sirima, K. Hamed, I. Soulama, 2014, Malaria Journal.

Abnormalities of Hemoglobin and Glucose-6-Phosphate-Dehydrogenase Deficiency in Children with Uncomplicated Malaria and Living in Banfora and Saponé, Two Different Malaria Setting of Burkina Faso

S. Sirima, I. Nébié, I. Soulama, 2019, International Journal of TROPICAL DISEASE & Health.

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials

T. Bousema, M. Niemi, C. Drakeley, 2018, PLoS ONE.

Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria

T. Clark, T. Bousema, C. Drakeley, 2019, Malaria Journal.

Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso

J. Ouédraogo, A. Djimde, S. Sirima, 2021, Antimicrobial agents and chemotherapy.

Prevalence of Plasmodium falciparum Chloroquine Resistance Transporter (Pfcrt76T) Mutation Associated with Antimalarial Drug Resistance in Two Different Epidemiological Setting (Banfora and Saponé) in Burkina Faso Few Years after the Implementation of Artemisnine Based Combination Therapy (ACTs)

S. Sirima, I. Soulama, A. Diarra, 2020, International Journal of Pathogen Research.

A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso

Bernhards Ogutu, B. Ogutu, S. Sirima, 2013, Malaria Journal.

Distribution of msp1, msp2 and eba175 Allelic Family According to Hemoglobin Genotype and G6PD Type from Children with Uncomplicated Malaria in Banfora Heath District (Burkina Faso)

Y. Idaghdour, S. Sirima, W. Abdrabou, 2020 .

Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children

T. Horii, S. Cousens, S. Sirima, 2022, Frontiers in Immunology.

Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial

Steve W Lindsay, Brian Faragher, S. Lindsay, 2018, The Lancet.

Phase I assessments of first-in-human administration of a novel malaria anti-sporozoite vaccine candidate, R21 in matrix-M adjuvant, in UK and Burkinabe volunteers

S. Sirima, B. Angus, A. Lawrie, 2019 .

Impact of Plasmodium falciparum infection on DNA methylation of circulating immune cells

Y. Idaghdour, S. Sirima, I. Soulama, 2023, Frontiers in genetics.

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials

T. Bousema, M. Niemi, C. Drakeley, 2018, PloS one.

G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials

A. Dicko, T. Clark, T. Bousema, 2021, Frontiers in Genetics.